Skip to main content

Table 1 Study characteristics – population characteristics

From: Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis

Study characteristics Number of studies (%)
Region of studya
 Andean Latin America 2 (0.5)
 Central Asia 3 (0.8)
 East Asia 12 (3.1)
 North Africa & Middle East 17 (4.4)
 South Asia 276 (71)
 Southeast Asia 38 (9.8)
 Sub-Saharan Africa, Central 6 (1.5)
 Sub-Saharan Africa, Eastern 14 (3.6)
 Sub-Saharan Africa, Western 21 (5.4)
Number of blood cultures screened
 0-99 13 (3.4)
 100-499 43 (11.2)
 500-999 30 (7.8)
 1000-4999 49 (12.8)
 5000+ 59 (15.4)
 Not stated 190 (49.5)
Specific age groups
 Adults only 5 (1.3)
 Children only 68 (17.7)
 No specified age restrictions/Adults and children 311 (81)
Reported pre-admission antibiotic use (proportion of patients in the study)b
 0 19 (4.9)
 1-25% 15 (3.8)
 26-50% 13 (3.3)
 51-75% 7 (1.8)
 76-100% 7 (1.8)
 Not stated 329 (84.4)
Reported case fatality rate
 0 61 (15.9)
 1-5% 24 (6.3)
 6-10% 2 (0.5)
 11-15% 1 (0.3)
 16-20% 2 (0.5)
 21-25% 1 (0.3)
 Not stated 293 (76.3)
Patient typec
 Inpatients 73 (19)
 Outpatients 14 (3.6)
 Outpatients & Emergency department 6 (1.6)
 Inpatients & Outpatients 44 (11.4)
 Community 7 (1.8)
 Not specified 241 (62.6)
  1. aThree studies reported isolates from multiple regions
  2. bSix studies reported the proportion of participants using antibiotics prior to testing separately for different sites or for persons infected with S. Typhi and S. Paratyphi A separately
  3. cOne study consisted of two separate parts, one was community based and the other in outpatients